Methoxyflavones, plant compounds found in some foods and many supplements, can interfere with how your body processes certain medications by blocking cellular transport proteins. A 2026 laboratory and animal study published in ACS Omega found that methoxyflavones more strongly inhibited drug transporters than regular flavonoids, and when given to rats, specific methoxyflavones altered how the body processed metformin and furosemide. The position of chemical modifications on these compounds determined the strength of the interaction, suggesting that not all methoxyflavones pose equal risk.
A new study from ACS Omega reveals that certain plant compounds called methoxyflavones, found in foods and supplements, can interfere with how your body absorbs and processes medications. Researchers tested different versions of these flavonoids and found they interact with transporters, which are like doorways that move drugs in and out of your cells. According to Gram Research analysis, some methoxyflavones affected how the body handled metformin (a diabetes medication) and furosemide (a water pill), suggesting people taking these drugs should be cautious about consuming high amounts of these plant compounds. The position of chemical modifications on these flavonoids matters, different arrangements created different levels of interference.
Key Statistics
A 2026 research article in ACS Omega found that methoxyflavones inhibited renal drug transporters OAT1, OAT3, and OCT2 more potently than regular flavonoids, with inhibitory strength varying based on the position of methoxy group substitution.
In animal studies, two methoxyflavones (3-MeO-FLV and 7-MeO-FLV) measurably altered metformin pharmacokinetics in rats, suggesting real-world drug-nutrient interactions involving organic cation transporter 2 (OCT2).
A 2026 ACS Omega study demonstrated that 6-MeO-FLV and 7-MeO-FLV created clear pharmacokinetic interactions with furosemide in rats, confirming that laboratory findings on transporter inhibition translate to effects in living organisms.
Cytotoxicity reversal assays in the 2026 study supported functional inhibition of MDR1 and BCRP efflux transporters by methoxyflavones, indicating that blocking effects observed in laboratory dishes actually work in cellular systems.
The Quick Take
- What they studied: Whether plant compounds called methoxyflavones can interfere with how your body moves medications in and out of cells through special transport proteins.
- Who participated: Laboratory cell studies and animal studies (rats) using different versions of methoxyflavones and common medications like metformin and furosemide.
- Key finding: Methoxyflavones blocked several important drug transporters more strongly than regular flavonoids, and this blocking effect changed how the body processed certain medications in live animals.
- What it means for you: If you take medications like metformin or furosemide and consume large amounts of methoxyflavone-rich foods or supplements, there’s a potential risk of drug interactions. Talk to your doctor before combining these, especially if you’re taking multiple medications.
The Research Details
Scientists started by testing methoxyflavones in laboratory dishes containing human cells with special transport proteins. These proteins act like gatekeepers, controlling which substances enter and leave cells. The researchers compared five different versions of flavonoids, one regular version and four with chemical modifications (methoxy groups) added at different positions.
They then moved to animal studies using rats to see if these laboratory findings actually happened in living bodies. They gave rats methoxyflavones along with two common medications: metformin (used for diabetes) and furosemide (a water pill). By measuring drug levels in the blood over time, they could see whether the flavonoids changed how the body processed these medications.
This two-step approach, starting with cells, then confirming with animals, helps researchers understand both how something works and whether it matters in real life.
Understanding drug-nutrient interactions is crucial because millions of people take medications daily while also consuming foods and supplements. If plant compounds can interfere with how medications work, people need to know about it to avoid unintended side effects or reduced medication effectiveness. This research specifically focuses on methoxyflavones because adding methoxy groups to flavonoids makes them more likely to cross cell membranes and potentially interact with drugs.
This study used established laboratory methods and confirmed findings in living animals, which strengthens confidence in the results. However, the research was conducted in rats, not humans, so results may not directly apply to people. The study tested specific methoxyflavones with specific medications, so the findings may not extend to all flavonoids or all drugs. The authors acknowledge that more research with larger compound sets is needed to fully understand these interactions.
What the Results Show
Methoxyflavones proved to be stronger blockers of drug transporters than regular flavonoids. Specifically, they inhibited three important uptake transporters (OAT1, OAT3, and OCT2) and two efflux transporters (MDR1 and BCRP) that normally help move drugs through the body.
The position of the methoxy group mattered significantly. Different arrangements of the chemical modification created different levels of transporter blocking, particularly for OAT1 and OCT2. This suggests that not all methoxyflavones are equally problematic, some positions create stronger interactions than others.
In the animal studies, two methoxyflavones (3-MeO-FLV and 7-MeO-FLV) noticeably changed how rats’ bodies processed metformin, suggesting interference with OCT2 transporters. For furosemide, two different methoxyflavones (6-MeO-FLV and 7-MeO-FLV) created clear interactions. These real-world results confirmed that the laboratory findings actually matter in living organisms.
Cytotoxicity reversal assays, tests showing whether cells could survive drug exposure, supported that methoxyflavones genuinely blocked the efflux transporters MDR1 and BCRP. This functional confirmation strengthens confidence that the blocking effects observed in laboratory dishes actually work in living systems. The variation in effects based on methoxy position suggests that chemical structure directly determines biological activity.
Previous research established that flavonoids can interact with drug transporters, but most studies focused on regular flavonoids without methoxy modifications. This research extends that knowledge by showing that adding methoxy groups, a common modification in nature and in supplements, actually increases the risk of these interactions. The findings align with the principle that more membrane-permeable compounds tend to interact more with transporters, but this study provides specific evidence for methoxyflavones.
The study was conducted in laboratory cells and rats, not humans, so results may not directly translate to people. Only a limited number of methoxyflavones and medications were tested, so the findings may not apply to all combinations. The study doesn’t establish how much of these compounds you’d need to consume to cause problems in real life. Long-term effects and interactions with other drugs weren’t examined. The research was published in 2026, so longer-term follow-up studies may provide additional insights.
The Bottom Line
If you take metformin, furosemide, or similar medications that depend on these transporters, avoid consuming very high amounts of methoxyflavone-rich supplements without consulting your doctor (moderate confidence). For people eating normal amounts of flavonoid-rich foods, the risk is likely lower, but those taking supplements should exercise caution (moderate confidence). Always inform your healthcare provider about supplements you’re taking, especially if you’re on multiple medications (high confidence).
People taking metformin (diabetes medication), furosemide (water pill), or other drugs that rely on OAT1, OAT3, OCT2, MDR1, or BCRP transporters should be most concerned. Those taking multiple medications simultaneously face higher interaction risk. People consuming large amounts of methoxyflavone supplements should be cautious. Conversely, people eating normal amounts of flavonoid-rich foods (berries, citrus, tea) likely face minimal risk.
Drug interactions typically occur within hours to days of combining substances, so effects would be relatively quick if they occur. However, the clinical significance depends on the specific medication and individual factors. Some people might notice changes in medication effectiveness or side effects, while others might experience nothing noticeable.
Frequently Asked Questions
Can flavonoid supplements interfere with my medications?
Methoxyflavone supplements may interfere with medications that depend on specific cellular transporters, particularly metformin and furosemide. A 2026 study found that certain methoxyflavones altered how rats’ bodies processed these drugs. Talk to your pharmacist before combining supplements with medications.
Which flavonoids are most likely to interact with drugs?
Methoxyflavones, flavonoids with added methoxy chemical groups, pose higher interaction risk than regular flavonoids. The 2026 research showed that 7-MeO-FLV and 6-MeO-FLV created the clearest drug interactions in animal studies, though effects varied by position of the methoxy group.
Do I need to avoid flavonoid-rich foods if I take medications?
Normal amounts of flavonoid-rich foods like berries, citrus, and tea are unlikely to cause problems. The interaction risk appears higher with concentrated supplements. However, if you take metformin or furosemide, discuss high-dose flavonoid supplements with your doctor before starting them.
How quickly would a flavonoid-drug interaction happen?
Drug interactions typically occur within hours to days of combining substances. Effects might include changes in medication effectiveness or unexpected side effects. If you notice your medication working differently after starting a supplement, contact your healthcare provider.
Are all methoxyflavones equally problematic?
No. A 2026 study found that the position of methoxy groups on flavonoid molecules significantly affected transporter inhibition strength. Some positions created stronger interactions than others, suggesting certain methoxyflavones pose greater interaction risk than others.
Want to Apply This Research?
- Log all supplements and high-dose flavonoid products consumed, noting the specific type (e.g., ‘quercetin supplement,’ ‘methoxylated flavonoid extract’) and amount. Track medication effectiveness markers relevant to your condition (blood sugar levels for metformin users, fluid retention for furosemide users) to identify any correlation with supplement timing.
- If you take transporter-dependent medications, set a reminder to discuss any flavonoid or polyphenol supplements with your pharmacist before starting them. Use the app to log when you start new supplements and monitor for any changes in how your medications seem to work over the following weeks.
- Create a medication-supplement interaction log within the app that tracks: (1) all medications and their dosing schedule, (2) all supplements with methoxyflavones or high-dose flavonoids, (3) relevant health markers (blood sugar, weight, energy levels), and (4) any unusual symptoms. Review this log monthly with your healthcare provider to identify patterns.
This article summarizes research findings and should not be considered medical advice. Methoxyflavones and flavonoid supplements may interact with medications, particularly metformin, furosemide, and drugs dependent on OAT1, OAT3, OCT2, MDR1, or BCRP transporters. If you take any prescription medications, consult your healthcare provider or pharmacist before starting new supplements, especially high-dose flavonoid products. Do not stop or change medications based on this information. The research was conducted in laboratory cells and rats; effects in humans may differ. Individual responses to drug-nutrient interactions vary based on genetics, dosage, timing, and other factors.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.
